Disproportionating enzyme

The first interest in the electroreduction of N02 or NO catalyzed by metal complexes is to model the activity of nitrite reductase enzymes.327 There is also an extensive growth in studies related to the development of metal complex-based electrochemical sensors for NO determination in biological and environmental samples 328 329 Nitrate disproportionates to nitric oxide and nitrate in aqueous solution. 

For DMS and DMTS, S-mothyl-L-cysteine sulfoxide is a precursor action of a C-S lyase enzyme yields methanesulfenic acid, CH3-S-OH, and hence methyl methanethiosulfinate, CH3-SO-S-CH3. Disproportionation reactions yield polysulfides such as DMS.56... 

Uncompetitive inhibition is extremely rare in nature, and can arise when the inhibitor binds to the enzyme-substrate complex, rather than to the free enzyme, as in competitive inhibition [111]. In uncompetitive inhibition, an increase in the concentration of the inhibitor requires a disproportionately large increase in the concentration of the substrate to maintain the same metabolic turnover. 

Superoxide dismutase enzymes are functional dimers of molecular weight (Mr) of approximately 32 kDa. The enzymes contain one copper ion and one zinc ion per subunit. Superoxide dismutase (SOD) metalloenzymes function to disproportionate the biologically harmful superoxide ion-radical according to the following reaction ... 

Bacterial SODs typically contain either nonheme iron (FeSODs) or manganese (MnSODs) at their active sites, although bacterial copper/zinc and nickel SODs are also known (Imlay and Imlay 1996 Chung et al. 1999). Catalases are usually heme-containing enzymes that catalyze disproportionation of hydrogen peroxide to water and molecular oxygen (Eq. 10.2) (Zamocky and Koller 1999 Loewen et al. 2000). 

Compound I is a two-electron oxidized enzyme intermediate containing a oxyferryl iron and a porphyrin cation radical while compound II is an one-electron oxidized intermediate (13), With lignin pa oxidase, as with other peroxidases, the substrate oxidation products are fir radicals which undergo nonenzymatic disproportionation reactions to give rise to the final products. 

The synthesis of ROS can be catalyzed by iron ions, for example. Reaction of O2 with FMN or FAD (see p. 32) also constantly produces ROS. By contrast, reduction of O2 by cytochrome c-oxidase (see p. 140) is clean, as the enzyme does not release the intermediates. In addition to antioxidants (B), enzymes also provide protection against ROS superoxide dismutase [1] breaks down ( dispropor-tionates ) two superoxide molecules into O2 and the less damaging H2O2. The latter is in turn disproportionated into O2 and H2O by heme-containing catalase [2]. 

In principle, one can never exactly duplicate the transition state, because transition state theory requires that such an intermediate species would disproportionate back to E-Substrate complex as well as proceed onward to E-Product complexes. However, the scheme shown in Fig. 3 permits one to estimate the maximal affinity that should be achievable if one were to approximate closely the electronic and stereochemical configuration of the enzyme and substrate in the transition state. An accurate estimation of requires detailed knowledge that the uncatalyzed reference reaction follows the same mechanism as the enzyme-catalyzed process. See Enzyme Proficiency Reference Reaction... 

In the case of digoxin we can visualize what is happening. The site of action and binding site of digoxin is to tissue Na+K+ATPase. This enzyme is distributed very widely in tissues, and particularly in excitable tissue, which depends on it to restore sodium/potassium balance to resting levels after excitation. Digoxin preferentially distributes therefore to these tissues, and a disproportionately small component is left in the plasma compartment from which we sample. 

This process is catalyzed by a variety of catalase enzymes, the most common being the heme catalases, which accomplish the two-electron chemistry of Eq. (12) at a mononuclear heme center. Here, both the iron and its surrounding porphyrin ligand participate to the extent of one electron each in the redox process. Manganese catalases contain a binuclear Mn center and cycle between Mn2(II,II) and Mn2(III,III) oxidation states while carrying out the disproportionation of H2O2. The enzyme can... 

Fluvoxamine, fluoxetine, and paroxetine have nonlinear pharmacokinetics, which means that dose increases lead to disproportionately greater increases in plasma drug levels (25). In contrast, citalopram and sertraline have linear pharmacokinetics. For these reasons, dose increases with fluvoxamine, fluoxetine, and paroxetine can lead to greater than proportional increases in concentration-dependent effects such as serotonin-mediated adverse effects (e.g., nausea) and inhibition of specific CYP enzymes. 

There is a linear relationship between dose and plasma drug levels (i.e., linear or first-order pharmacokinetics) in normal and ultrarapid metabolizers. In these individuals, the earlier equation can be used to predict the daily dose needed to produce a specific plasma drug level once TDM has been done to estimate the patient s elimination rate. In poor metabolizers, TCAs follow nonlinear pharmacokinetics (i.e., disproportionate increases in plasma drug levels with dose increases) because they lack the CYP 2D6 and must use lower affinity enzymes to metabolize these drugs. 

The enzyme copper, zinc superoxide dismutase (Cu,Zn-SOD, EC 1.15.1.1) catalyzes the disproportionation of superoxide anion to dioxygen and hydrogen peroxide (equations 1 and 2). Crystallographic data can be found in References 41-46. This antioxidant enzyme is present in the cytosol and mitochondrial intermembrane space of eukaryotic cells and in the periplasmic space of bacterial cells as a homodimer of 32 kDa. Each monomer binds one copper and one zinc ion. The reaction mechanism involves the... 

Carnitine and its esters are present in all biological fluids, and depending on the enzyme defect, a particular acylcarnitine pattern becomes apparent where those acyl-carnitine species serving as direct substrates for the defective enzyme accumulate disproportionately to the down- and upstream metabolites (Table 3.2.1). 

---